Please login to the form below

Random42 appoints Bill Collis as Chairman

Random42 is pleased to announce the appointment of Bill Collis as their new Chairman.

Bill has a scientific background with a PhD in Signal Processing and extensive experience in various leadership roles, both executive and non-executive. He currently acts as both Chairman and Director for various other private equity backed companies. In addition to Random42, he is also Chairman of Disguise and sits on the boards of Cubic Motion and Exocad.

Previously, Bill has served as CEO and President of The Foundry, where he led over a decade of change and innovation, transforming a niche London-based visual effects software company into a global, award-winning tech company. He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.

Random42 CEO and Medical Director, Ben Ramsbottom, commented on the appointment: "We are excited to bring Bill onboard, with his extensive knowledge of the animation industry, as well as his own experience building a market leading company that has gone through rapid growth he is the perfect fit to aid us on the next phase of Random42's development."

Bill's leadership skills earned him an Ernst & Young Entrepreneur Of The Year award in 2012 and he is also the proud owner of numerous patents, a major feature movie credit, plus a prestigious Scientific and Technical Award from the Academy of Motion Picture Arts and Sciences for technology contributions to film.

Bill commented: "I'm thrilled to be working with Ben and the rest of the Random42 team. Random42 are the clear market leaders in medical animation, VR and AR for the pharmaceutical industry and I'm looking forward to helping them continue their rapid growth over the coming years."

About Random42  
Random42 Scientific Communication is a leading scientific communication studio specialising in medical animation and education, scientific virtual reality, interactive and visually engaging solutions for global pharmaceutical and biotechnology companies. In their 26-year history they have produced core digital assets for over 650 product launches to date and won over 150 industry awards.

For further information please contact - Random42 Scientific Communication
A - 51 Great Marlborough Street, London, W1F 7JT
E - info@random42.com
T - +44-(0)-20-7734-6001
W - www.random42.com

8th May 2018

Share

Company Details

Random42 Scientific Communication

+44(0)20-7734-6001

Contact Website

Address:
51 Great Marlborough Street
London
W1F 7JT
United Kingdom

Latest content on this profile

Random42 Attending Jefferies 2018 London Healthcare Conference
Random42 will be attending The Jefferies 2018 Healthcare Conference taking place November 14th and 15th in London.
Random42 Scientific Communication
Random42 exhibiting at BIO-Europe 2018
Random42 will be attending BioEurope in Copenhagen from November 5th – 7th.
Random42 Scientific Communication
Random42 Partner with MedCity for BioJapan 2018
Random42 are pleased to announce that they will be attending BioJapan in Yokohama, in Partnership with MedCity, from October 10th to 12th.
Random42 Scientific Communication
Random42 Exhibiting at BioCap Conference 2018
Random42 announce they will be attending the seventh annual BioCap Conference on Thursday 27th September at Alderley Park, Cheshire
Random42 Scientific Communication
Random42 Scientific Communication at eyeforpharma Barcelona!

Random42 Scientific Communication
Random42 Scientific Communication Showreel 2015
This showreel is a selection of our best medical animation work that has been produced over the last few years. With 3D medical animation we can fly around a virtual human body. As viewers, we can travel with red blood cells along arteries to explore cardiovascular concerns, or down the airways and into the lungs to illustrate respiratory issues. We can observe the functioning synapses of the brain or watch cells divide. When a drug enters the scene, we can see for ourselves how it interacts with the complex mechanisms of the human body.
Random42 Scientific Communication